Skip to content
NewsBlazeAU – Lifestyle
Author:
LENZ Therapeutics, Inc.
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
March 10, 2026
←
Previous Page
1
2